false
OasisLMS
Catalog
ASGE Postgraduate Course at ACG 2022: Expanding th ...
Phillip Ge Malignant Gastric Outlet Obstruction Du ...
Phillip Ge Malignant Gastric Outlet Obstruction Duodenal Stents
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The speaker presents a rebuttal in a debate about the effectiveness of duodenal stenting as a therapy for pancreatic cancer patients with gastric outlet obstruction. They argue that duodenal stenting has a long track record with proven efficacy, supported by multiple studies and guidelines. They acknowledge that stent occlusion is a problem but point out that most stents still last longer than the survival time of pancreatic cancer patients. They question the adoption and widespread use of EUSGJ, highlighting the limited training opportunities and the expertise required. They also mention the advancements in robotic surgery as a potential alternative to EUSGJ. The speaker concludes that the choice between duodenal stents and EUSGJ should be personalized and multidisciplinary based on patient factors and long-term survival prospects. They argue that EUSGJ currently occupies a narrow niche and needs significant improvement before it can be widely adopted. They emphasize the importance of a safe and widely accessible procedure.
Keywords
duodenal stenting
pancreatic cancer patients
EUSGJ
robotic surgery
personalized treatment
×
Please select your language
1
English